TrialJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2025
A phase IIb single-center study to assess the efficacy of apremilast for the treatment of nummular eczema.
Alexander Böhner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papertrialcites it